Consult & Labs
Meet your provider in person or via telehealth. We review your history, goals and baseline lab work to confirm you’re a candidate.
Physician-Guided Weight Management
Physician-guided GLP-1 programs featuring semaglutide and tirzepatide, with real medical oversight, lab work, dosing titration and support at every step. In-clinic across Greater Houston, or by telehealth in TX, NC & SC.
The Medications
The GLP-1 receptor agonist behind Ozempic® and Wegovy®. Semaglutide reduces appetite, slows gastric emptying and helps regulate blood sugar, supporting meaningful, sustained weight loss in clinical studies. Weekly self-administered injection with gradual dose titration.
Semaglutide GuideThe dual GIP/GLP-1 agonist behind Mounjaro® and Zepbound®. By activating two metabolic pathways, tirzepatide has shown some of the strongest weight loss results ever studied. Weekly injection, titrated by your provider for comfort and results.
Tirzepatide GuideAn investigational once-weekly medicine that targets GIP, GLP-1 and glucagon pathways. Lilly announced positive topline results from the Phase 3 TRIUMPH-1 obesity trial in May 2026, with additional Phase 3 results anticipated. Retatrutide is not FDA-approved and is not currently available for prescribing.
Follow the Phase 3 NewsHow It Works
Meet your provider in person or via telehealth. We review your history, goals and baseline lab work to confirm you’re a candidate.
Your provider selects the right medication and starting dose, plus nutrition and lifestyle guidance to amplify results.
Monthly check-ins help adjust dosing, manage side effects and maintain momentum. We’re a text away between visits.
As you approach goal weight, we build a maintenance strategy, including body sculpting and peptide options to support your new baseline.
Why Identity
Plenty of websites will ship you a vial. We do it differently: a licensed provider who knows your labs, monitors your progress and adjusts your plan, backed by a licensed U.S. partner pharmacy.
And because we’re a full aesthetics practice, we can care for the whole journey: skin quality, facial volume and body contouring as your shape changes.
Questions
GLP-1 therapy is generally appropriate for adults with a BMI of 30+, or 27+ with a weight-related condition, but candidacy is always determined by your provider after reviewing your health history and labs. Certain conditions, including a personal or family history of medullary thyroid cancer or MEN2, rule out treatment.
In clinical trials, patients on semaglutide lost on average around 15% of body weight, and tirzepatide patients lost up to roughly 20% over 68–72 weeks alongside diet and lifestyle changes. Individual results vary, and consistency and follow-up matter.
Nausea, constipation and fatigue are most common, especially during dose increases. We titrate slowly and stay in close contact to keep side effects manageable. Your provider will review the full safety profile at your consultation.
Program pricing depends on medication and dose. We’ll walk you through exact pricing at your consultation, and financing is available through Cherry. No insurance is required.
Yes. Consultations, follow-ups and medication shipment can all be handled remotely for patients in Texas, North Carolina and South Carolina.